Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Keratosis, Actinic 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1

Interventions

Paclitaxel 328 Carboplatin 323 Bevacizumab 171 Gemcitabine 106 liposomal doxorubicin 104 pembrolizumab 100 Topotecan 94 Cyclophosphamide 94 olaparib 92 Cisplatin 92 niraparib 69 Docetaxel 57 Taxes 52 Doxorubicin 51 Drug Therapy 45 fludarabine 39 Filgrastim 39 Nivolumab 37 Magnetic Resonance Spectroscopy 34 Surveys and Questionnaires 33 Specimen Handling 33 Etoposide 32 Hyperthermic Intraperitoneal Chemotherapy 31 Blood Specimen Collection 29 Immunoglobulin G 27 Disulfides 27 Peripheral Blood Stem Cell Transplantation 26 Cytoreduction Surgical Procedures 25 Albumin-Bound Paclitaxel 25 durvalumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Methylation × Clear all

NCT00173407 2012-12-27

PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion

National Taiwan University Hospital

Phase NA Withdrawn

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡